ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2024. The put-call ratio across all filers is 55.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,457 | +111325.0% | 1,231 | 0.0% | 0.00% | – |
Q1 2024 | $4 | -33.3% | 1,231 | 0.0% | 0.00% | – |
Q4 2023 | $6 | -14.3% | 1,231 | -5.2% | 0.00% | -100.0% |
Q3 2023 | $7 | -12.5% | 1,298 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $8 | -27.3% | 1,298 | +5.4% | 0.00% | 0.0% |
Q1 2023 | $11 | +22.2% | 1,231 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $9 | -99.9% | 1,231 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $8,000 | -20.0% | 1,231 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $10,000 | -41.2% | 1,231 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $17,000 | -51.4% | 1,231 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $35,000 | -16.7% | 1,231 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $42,000 | -17.6% | 1,231 | 0.0% | 0.01% | -25.0% |
Q2 2021 | $51,000 | +410.0% | 1,231 | +435.2% | 0.01% | +300.0% |
Q1 2021 | $10,000 | -52.4% | 230 | -34.3% | 0.00% | -50.0% |
Q4 2020 | $21,000 | +23.5% | 350 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $17,000 | +142.9% | 350 | +125.8% | 0.00% | +100.0% |
Q2 2020 | $7,000 | – | 155 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Matrix Capital Management Company, LP | 17,332,191 | $535,565,000 | 13.21% |
TIGER MANAGEMENT L.L.C. | 1,115,411 | $34,466,000 | 13.06% |
VIKING GLOBAL INVESTORS LP | 38,406,607 | $1,186,764,000 | 6.18% |
Senator Investment Group LP | 5,113,085 | $146,145,000 | 3.67% |
Casdin Capital, LLC | 463,125 | $14,310,562,000 | 1.48% |
Graticule Asia Macro Advisors LLC | 356,326 | $11,010,000 | 0.86% |
Ratan Capital Management LP | 41,272 | $1,275,000 | 0.67% |
Rock Springs Capital Management LP | 545,000 | $16,841,000 | 0.67% |
MYDA Advisors LLC | 34,000 | $1,051,000 | 0.48% |
Aristotle Atlantic Partners, LLC | 50,459 | $1,559,000 | 0.45% |